Ironwood Pharmaceuticals, Inc. - (IRWD) Company Bio
Ironwood Pharmaceuticals engages in the research, development, and commercialization of human therapeutic products, with a key focus being the treatment of adult men and women suffering from irritable bowel syndrome. The company was founded in 1998 and is based in Cambridge, Massachusetts.
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences in September: 2020 Wells Fargo Virtual Healthcare Conference on Wednesday, September 9, 2020 at 11:20 a.m. ET Morgan Stanley Virtual 18th Annual Global Healthcare Conference on Monday, September 14, 2020 at 9:00 a.m. ET A live webcast of Ironwood’s fireside chats will be accessible through the Investors section of the company’s website at www.iro
Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2020 Earnings Conference Call August 6, 2020 08:30 am ET Company Participants Meredith Kaya - Vice President, Investor Relations and Corporate Communications Mark Mallon - Chief Executive Officer Tom McCourt - President Gina Consylman - Senior Vice President and Chief Financial Officer Presentation Operator Ladies...